Neuroleptic malignant syndrome with prolonged catatonia in a dopa-responsive dystonia patient.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12370475.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors describe a patient with dopa-responsive dystonia who developed neuroleptic malignant syndrome with prolonged catatonia following treatment with neuroleptic agents. Use of these agents probably expanded the patient's neuronal dysfunction beyond the nigrostriatal system to involve multiple dopaminergic systems. Electroconvulsive treatment alleviated the prolonged catatonia.
Medical subject headings
- Catatonia
- Dystonia
- Levodopa
- Neuroleptic Malignant Syndrome